MICRUS ENDOVASCULAR CORP

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$68.6M

1,038 transactions

Summary

MICRUS ENDOVASCULAR CORP is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $4.0MSales: $33.8M23 insiders

Date	Insider	Type	Value
2010-09-27	Colloton Robert C(VP Global Sales & Marketing)	D	$1.0M
2010-09-27	Colloton Robert C(VP Global Sales & Marketing)	D	$946K
2010-09-27	Bruguera Carolyn M(General Counsel)	D	$684K
2010-09-27	Colloton Robert C(VP Global Sales & Marketing)	D	$579K
2010-09-27	Colloton Robert C(VP Global Sales & Marketing)	D	$229K
2010-09-27	Bruguera Carolyn M(General Counsel)	D	$229K
2010-09-27	Bruguera Carolyn M(General Counsel)	D	$214K
2010-09-27	Colloton Robert C(VP Global Sales & Marketing)	D	$167K
2010-09-27	Bruguera Carolyn M(General Counsel)	D	$126K
2010-09-27	Colloton Robert C(VP Global Sales & Marketing)	D	$126K
2010-09-27	Bruguera Carolyn M(General Counsel)	D	$97K
2010-09-27	Colloton Robert C(VP Global Sales & Marketing)	D	$72K
2010-09-27	Bruguera Carolyn M(General Counsel)	D	$55K
2010-09-27	Bruguera Carolyn M(General Counsel)	D	$52K
2010-09-27	Colloton Robert C(VP Global Sales & Marketing)	D	$43K
2010-09-27	Bruguera Carolyn M(General Counsel)	D	$27K
2010-09-27	Bruguera Carolyn M(General Counsel)	D	$26K
2010-09-27	Bruguera Carolyn M(General Counsel)	D	$19K
2010-09-27	Colloton Robert C(VP Global Sales & Marketing)	D	$16K
2010-09-27	Bruguera Carolyn M(General Counsel)	D	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

MICRUS ENDOVASCULAR CORP — Contributions, Lobbying & Contracts | Poliscope